Clinical Trial Update: Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of AAV5-hFIX in severe or moderately severe Hemophilia B has completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• AAV5-hFIX

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia B | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-06-27